Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.

Antiviral therapy - 1 Jan 2007

Lohse Nicolai, Jørgensen Louise B, Kronborg Gitte, Møller Axel, Kvinesdal Birgit, Sørensen Henrik T, Obel Niels, Gerstoft Jan

Abstract excerpt

OBJECTIVE: To examine the prevalence of drug-resistance-associated mutations in HIV patients with triple-drug class virological failure (TCF) and their association with long-term mortality. DESIGN: Population-based study from the Danish HIV Cohort Study (DHCS). METHODS: We included all patients in the DHCS who experienced TCF between January 1995 and November 2004, and we performed genotypic resistance tests for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Kaplan-Meier Estimate

Share to Treatment Failure

Source

Identifiers

PMID: 17926645

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.PMID 17926645Read ↗

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.Semantic proximity Read ↗

Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.Semantic proximity Read ↗

Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).Semantic proximity Read ↗

Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy.Semantic proximity Read ↗

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.Semantic proximity Read ↗

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.Semantic proximity Read ↗

Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.Semantic proximity Read ↗

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.Semantic proximity Read ↗

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.Semantic proximity Read ↗

Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.Semantic proximity Read ↗

Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.Semantic proximity Read ↗

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.